Eosinophilic Esophagitis in Children and Adults

A Systematic Review and Consensus Recommendations for Diagnosis and Treatment. Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition

Glenn T. Furuta, Chris A. Liacouras, Margaret H. Collins, Sandeep Gupta, Chris Justinich, Phil E. Putnam, Peter Bonis, Eric Hassall, Alex Straumann, Marc E. Rothenberg

Research output: Contribution to journalArticle

1122 Citations (Scopus)

Abstract

During the last decade, clinical practice saw a rapid increase of patients with esophageal eosinophilia who were thought to have gastroesophageal reflux disease (GERD) but who did not respond to medical and/or surgical GERD management. Subsequent studies demonstrated that these patients had a "new" disease termed eosinophilic esophagitis (EE). As recognition of EE grew, so did confusion surrounding diagnostic criteria and treatment. To address these issues, a multidisciplinary task force of 31 physicians assembled with the goal of determining diagnostic criteria and making recommendations for evaluation and treatment of children and adults with suspected EE. Consensus recommendations were based upon a systematic review of the literature and expert opinion. EE is a clinicopathological disease characterized by (1) Symptoms including but not restricted to food impaction and dysphagia in adults, and feeding intolerance and GERD symptoms in children; (2) ≥ 15 eosinophils/HPF; (3) Exclusion of other disorders associated with similar clinical, histological, or endoscopic features, especially GERD. (Use of high dose proton pump inhibitor treatment or normal pH monitoring). Appropriate treatments include dietary approaches based upon eliminating exposure to food allergens, or topical corticosteroids. Since EE is a relatively new disease, the intent of this report is to provide current recommendations for care of affected patients and defining gaps in knowledge for future research studies.

Original languageEnglish
Pages (from-to)1342-1363
Number of pages22
JournalGastroenterology
Volume133
Issue number4
DOIs
StatePublished - Oct 2007

Fingerprint

Eosinophilic Esophagitis
Gastroenterology
Gastroesophageal Reflux
Pediatrics
Therapeutics
Food
Proton Pump Inhibitors
Expert Testimony
Eosinophilia
Advisory Committees
Deglutition Disorders
Disease Management
Eosinophils
Allergens
Patient Care
Adrenal Cortex Hormones
Physicians

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Eosinophilic Esophagitis in Children and Adults : A Systematic Review and Consensus Recommendations for Diagnosis and Treatment. Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. / Furuta, Glenn T.; Liacouras, Chris A.; Collins, Margaret H.; Gupta, Sandeep; Justinich, Chris; Putnam, Phil E.; Bonis, Peter; Hassall, Eric; Straumann, Alex; Rothenberg, Marc E.

In: Gastroenterology, Vol. 133, No. 4, 10.2007, p. 1342-1363.

Research output: Contribution to journalArticle

Furuta, Glenn T. ; Liacouras, Chris A. ; Collins, Margaret H. ; Gupta, Sandeep ; Justinich, Chris ; Putnam, Phil E. ; Bonis, Peter ; Hassall, Eric ; Straumann, Alex ; Rothenberg, Marc E. / Eosinophilic Esophagitis in Children and Adults : A Systematic Review and Consensus Recommendations for Diagnosis and Treatment. Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. In: Gastroenterology. 2007 ; Vol. 133, No. 4. pp. 1342-1363.
@article{62c1027e68984d12b758a223318cf4f3,
title = "Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and Treatment. Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition",
abstract = "During the last decade, clinical practice saw a rapid increase of patients with esophageal eosinophilia who were thought to have gastroesophageal reflux disease (GERD) but who did not respond to medical and/or surgical GERD management. Subsequent studies demonstrated that these patients had a {"}new{"} disease termed eosinophilic esophagitis (EE). As recognition of EE grew, so did confusion surrounding diagnostic criteria and treatment. To address these issues, a multidisciplinary task force of 31 physicians assembled with the goal of determining diagnostic criteria and making recommendations for evaluation and treatment of children and adults with suspected EE. Consensus recommendations were based upon a systematic review of the literature and expert opinion. EE is a clinicopathological disease characterized by (1) Symptoms including but not restricted to food impaction and dysphagia in adults, and feeding intolerance and GERD symptoms in children; (2) ≥ 15 eosinophils/HPF; (3) Exclusion of other disorders associated with similar clinical, histological, or endoscopic features, especially GERD. (Use of high dose proton pump inhibitor treatment or normal pH monitoring). Appropriate treatments include dietary approaches based upon eliminating exposure to food allergens, or topical corticosteroids. Since EE is a relatively new disease, the intent of this report is to provide current recommendations for care of affected patients and defining gaps in knowledge for future research studies.",
author = "Furuta, {Glenn T.} and Liacouras, {Chris A.} and Collins, {Margaret H.} and Sandeep Gupta and Chris Justinich and Putnam, {Phil E.} and Peter Bonis and Eric Hassall and Alex Straumann and Rothenberg, {Marc E.}",
year = "2007",
month = "10",
doi = "10.1053/j.gastro.2007.08.017",
language = "English",
volume = "133",
pages = "1342--1363",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Eosinophilic Esophagitis in Children and Adults

T2 - A Systematic Review and Consensus Recommendations for Diagnosis and Treatment. Sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition

AU - Furuta, Glenn T.

AU - Liacouras, Chris A.

AU - Collins, Margaret H.

AU - Gupta, Sandeep

AU - Justinich, Chris

AU - Putnam, Phil E.

AU - Bonis, Peter

AU - Hassall, Eric

AU - Straumann, Alex

AU - Rothenberg, Marc E.

PY - 2007/10

Y1 - 2007/10

N2 - During the last decade, clinical practice saw a rapid increase of patients with esophageal eosinophilia who were thought to have gastroesophageal reflux disease (GERD) but who did not respond to medical and/or surgical GERD management. Subsequent studies demonstrated that these patients had a "new" disease termed eosinophilic esophagitis (EE). As recognition of EE grew, so did confusion surrounding diagnostic criteria and treatment. To address these issues, a multidisciplinary task force of 31 physicians assembled with the goal of determining diagnostic criteria and making recommendations for evaluation and treatment of children and adults with suspected EE. Consensus recommendations were based upon a systematic review of the literature and expert opinion. EE is a clinicopathological disease characterized by (1) Symptoms including but not restricted to food impaction and dysphagia in adults, and feeding intolerance and GERD symptoms in children; (2) ≥ 15 eosinophils/HPF; (3) Exclusion of other disorders associated with similar clinical, histological, or endoscopic features, especially GERD. (Use of high dose proton pump inhibitor treatment or normal pH monitoring). Appropriate treatments include dietary approaches based upon eliminating exposure to food allergens, or topical corticosteroids. Since EE is a relatively new disease, the intent of this report is to provide current recommendations for care of affected patients and defining gaps in knowledge for future research studies.

AB - During the last decade, clinical practice saw a rapid increase of patients with esophageal eosinophilia who were thought to have gastroesophageal reflux disease (GERD) but who did not respond to medical and/or surgical GERD management. Subsequent studies demonstrated that these patients had a "new" disease termed eosinophilic esophagitis (EE). As recognition of EE grew, so did confusion surrounding diagnostic criteria and treatment. To address these issues, a multidisciplinary task force of 31 physicians assembled with the goal of determining diagnostic criteria and making recommendations for evaluation and treatment of children and adults with suspected EE. Consensus recommendations were based upon a systematic review of the literature and expert opinion. EE is a clinicopathological disease characterized by (1) Symptoms including but not restricted to food impaction and dysphagia in adults, and feeding intolerance and GERD symptoms in children; (2) ≥ 15 eosinophils/HPF; (3) Exclusion of other disorders associated with similar clinical, histological, or endoscopic features, especially GERD. (Use of high dose proton pump inhibitor treatment or normal pH monitoring). Appropriate treatments include dietary approaches based upon eliminating exposure to food allergens, or topical corticosteroids. Since EE is a relatively new disease, the intent of this report is to provide current recommendations for care of affected patients and defining gaps in knowledge for future research studies.

UR - http://www.scopus.com/inward/record.url?scp=34848880717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848880717&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2007.08.017

DO - 10.1053/j.gastro.2007.08.017

M3 - Article

VL - 133

SP - 1342

EP - 1363

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -